Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice

American Journal of Pathology

Volumn 163, Issue 4, 2003, Pages 1677-1686

  Van Haperen, Rien ^a   Cheng, Caroline ^a   Mees, Barend M E ^a   Van Deel, Elza ^a   De Waard, Monique ^a   Van Damme, Luc C A ^a   Van Gent, Teus ^a   Van Aken, Thijs ^a   Krams, Rob ^a   Duncker, Dirk J ^a   De Crom, Rini ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE; GREEN FLUORESCENT PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ISCHEMIA; LUNG ARTERY PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SHEAR STRESS; TRANSGENIC MOUSE;

EID: 0141648341     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63524-9     Document Type: Article

References (46)

1. Li H, Forstermann U: Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000, 190:244-254
2. Harrison DG: Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997, 100:2153-2157
3. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N: Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 2000, 105:451-458
4. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL: Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104:448-454
5. Laufs U, La Fata V, Plutzky J, Liao JK: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998, 97:1129-1135
6. Kano H, Hayashi T, Sumi D, Esaki T, Asai Y, Thakur NK, Jayachandran M, Iguchi A: A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA. Biochem Biophys Res Commun 1999, 259:414-419
7. Sessa WC: Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins? Trends Mol Med 2001, 7:189-191
8. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ: Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992, 90:2092-2096
9. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993, 268:17478-17488
10. Forstermann U, Boissel JP, Kleinert H: Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). EMBO J 1998, 12:773-790
11. Fulton D, Gratton JP, Sessa WC: Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001, 299:818-824
12. Govers R, Rabelink TJ: Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 2001, 280:F193-F206
13. Marletta MA: Another activation switch for endothelial nitric oxide synthase: why does it have to be so complicated? Trends Biochem Sci 2001, 26:519-521
14. Fulton D, Fontana J, Sowa G, Gratton JP, Lin M, Li KX, Michell B, Kemp BE, Rodman D, Sessa WC: Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem 2002, 277:4277-4284
15. Bakker CE, de Diego Otero Y, Bontekoe C, Raghoe P, Luteijn T, Hoogeveen AT, Oostra BA, Willemsen R: Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res 2000, 258:162-170
16. Van Haperen R, De Waard M, Van Deel E, Mees B, Kutryk M, Van Aken T, Hamming J, Grosveld F, Duncker DJ, De Crom R: Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide. J Biol Chem 2002, 277:48803-48807
17. Lie J, de Crom R, van Gent T, van Haperen R, Scheek L, Lankhuizen I, van Tol A: Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J Lipid Res 2002, 43:1875-1880
18. Laumonnier Y, Nadaud S, Agrapart M, Soubrier F: Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J Biol Chem 2000, 275:40732-40741
19. van Haperen R, van Tol A, Vermeulen P, Jauhiainen M, van Gent T, van den Berg P, Ehnholm S, Grosveld F, van der Kamp A, de Crom R: Human plasma phospholipid transfer protein increases the anti-atherogenic potential of high-density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000, 20:1082-1088
20. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y, Yokoyama M: Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice over-expressing endothelial nitric oxide synthase. J Clin Invest 1998, 102:2061-2071
21. Hurford WE: Inhaled nitric oxide. Respir Care Clin N Am 2002, 8:261-279
22. Sitbon O, Humbert M, Simonneau G: Primary pulmonary hypertension: current therapy. Prog Cardiovasc Dis 2002, 45:115-128
23. Huang WY, Aramburu J, Douglas PS, Izumo S: Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 2000, 6:482-483
24. van Haperen R, van Tol A, van Gent T, Scheek L, Visser P, van der Kamp A, Grosveld F, de Crom R: Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J Biol Chem 2002, 277:48938-48943
25. Zhang R, Min W, Sessa WC: Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 1995, 270:15320-15326
26. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, Miller TL, Chan Y, Atkins J, Wang Y, Marsden PA: Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 1999, 274:3076-3093
27. Wu KK: Regulation of endothelial nitric oxide synthase activity and gene expression. Ann NY Acad Sci 2002, 962:122-130
28. Topper JN, Cai J, Falb D, Gimbrone MA Jr: Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 1996, 93:10417-10422
29. Go YM, Boo YC, Park H, Maland MC, Patel R, Pritchard KA Jr, Fujio Y, Walsh K, Darley-Usmar V, Jo H: Protein kinase B/Akt activates c-Jun NH(2)-terminal kinase by increasing NO production in response to shear stress. J Appl Physiol 2001, 91:1574-1581
30. Blair A, Shaul PW, Yuhanna IS, Conrad PA, Smart EJ: Oxidized low-density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 1999, 274:32512-32519
31. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ: High-density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 2000, 275:11278-11283
32. Everson WV, Smart EJ: Influence of caveolin, cholesterol, and lipoproteins on nitric oxide synthase: implications for vascular disease. Trends Cardiovasc Med 2001, 11:246-250
33. Schubert W, Frank PG, Woodman SE, Hyogo H, Cohen DE, Chow CW, Lisanti MP: Microvascular hyperpermeability in caveolin-1 (-/-) knockout mice: treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 2002, 277:40091-40098
34. Michel JB, Feron O, Sase K, Prabhakar P, Michel T: Caveolin versus calmodulin: counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 1997, 272:25907-25912
35. Michel T, Feron O: Nitric oxide synthases: which, where, how, and why? J Clin Invest 1997, 100:2146-2152
36. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC: Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998, 392:821-824
37. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, McCabe TJ, Sessa WC: Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro: evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem 2000, 275:22268-22272
38. Dedio J, Konig P, Wohlfart P, Schroeder C, Kummer W, Muller-Esterl W: NOSIP, a novel modulator of endothelial nitric oxide synthase activity. EMBO J 2001, 15:79-89
39. Zimmermann K, Opitz N, Dedio J, Renne C, Muller-Esterl W, Oess S: NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2002, 99:17167-17172
40. Robinson LJ, Michel T: Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci USA 1995, 92:11776-11780
41. Sakoda T, Hirata K, Kuroda R, Miki N, Suematsu M, Kawashima S, Yokoyama M: Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxide. Mol Cell Biochem 1995, 152:143-148
42. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601
43. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605
44. Venema VJ, Marrero MB, Venema RC: Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun 1996, 226:703-710
45. Liu J, Hughes TE, Sessa WC: The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol 1997, 137:1525-1535
46. Sowa G, Liu J, Papapetropoulos A, Rex-Haffner M, Hughes TE, Sessa WC: Trafficking of endothelial nitric-oxide synthase in living cells: quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion. J Biol Chem 1999, 274:22524-22531